Alpha Teknova, Inc. SEC filings TKNO
Alpha Teknova, Inc. has 221 filings in SEC EDGAR's recent list, going back to Apr 5, 2021. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 21, 2026 | — |
| 424B5 | Prospectus supplement | Oct 20, 2026 | — |
| S-3 | Shelf registration | Jul 10, 2025 | — |
| S-8 | Employee stock plan registration | Mar 10, 2025 | — |
| 424B3 | Prospectus | Aug 30, 2024 | — |
| S-1 | Registration statement | Aug 23, 2024 | — |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 424B3 | Prospectus | Nov 9, 2023 | — |
| S-1 | Registration statement | Oct 25, 2023 | — |
| 424B5 | Prospectus supplement | Sep 19, 2023 | — |
| 424B5 | Prospectus supplement | Mar 30, 2023 | — |
| S-8 | Employee stock plan registration | Jan 30, 2023 | — |
| S-3 | Shelf registration | Jul 1, 2022 | — |
| S-8 | Employee stock plan registration | Jan 27, 2022 | — |
| S-8 | Employee stock plan registration | Jun 29, 2021 | — |
| 424B4 | Prospectus | Jun 25, 2021 | — |
| S-1MEF | Filing | Jun 24, 2021 | — |
| S-1/A | Amended registration statement | Jun 21, 2021 | — |
| S-1 | Registration statement | Jun 4, 2021 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- TKNO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hollister, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850902
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.